2022 committee members:
Jolanta Piszczek, BSc Pharm, PharmD, MSc
Agnes Lee, MD, MSc
Alissa Wright, MD, MSc
Alicia Rahier, BSc Pharm
David Migneault, MDCM, MSBe
I fan Kuo, PharmD, MSc
Rita McCracken, MD, PhD
Jennifer Grant, MDCM
Luke Chen, MD
Josh Douglas, MD
David Sweet, MD
Tim Lau, PharmD
Cesilia Nishi, PharmD
Nilu Partovi, PharmD
Srinivas Murthy, MD, MHS
Eric Partlow, MD
Anish Mitra, MD
Ryan Foster, MD
Elizabeth Parfitt, MD
Sean Gorman, BPharm, PharmD
Angus Kinkade, PharmD, MSc
Author profile
British Columbia COVID-19 Therapeutics Committee
Recently, two novel agents have become available in BC for the treatment of COVID-19 in mild to moderately ill patients: a direct-acting oral antiviral, nirmatrelvir/ritonavir, and an IV antiviral, remdesivir. A... Read More
To date (22 April 2020), there are no Health Canada–approved COVID-19 pharmacologic treatments, yet there is intense interest and media coverage of potential pharmacological agents.[1,2] In BC, we have had the benefit... Read More